UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1244) 1244
science & technology (1094) 1094
life sciences & biomedicine (1031) 1031
male (882) 882
hiv infections - drug therapy (872) 872
female (785) 785
adult (659) 659
infectious diseases (581) 581
benzoxazines - adverse effects (499) 499
anti-hiv agents - adverse effects (490) 490
efavirenz (472) 472
benzoxazines (441) 441
middle aged (431) 431
benzoxazines - therapeutic use (430) 430
biological and medical sciences (426) 426
medical sciences (419) 419
anti-hiv agents - therapeutic use (417) 417
antiviral agents (380) 380
pharmacology & pharmacy (358) 358
hiv (346) 346
benzoxazines - administration & dosage (338) 338
reverse transcriptase inhibitors - adverse effects (327) 327
pharmacology. drug treatments (316) 316
treatment outcome (296) 296
reverse transcriptase inhibitors - therapeutic use (276) 276
viral diseases (271) 271
oxazines - adverse effects (270) 270
drug therapy, combination (268) 268
immunology (263) 263
drug therapy (259) 259
antiretroviral drugs (257) 257
human immunodeficiency virus--hiv (257) 257
human viral diseases (254) 254
aids/hiv (252) 252
anti-hiv agents - administration & dosage (251) 251
viral diseases of the lymphoid tissue and the blood. aids (233) 233
virology (227) 227
animals (217) 217
antibiotics. antiinfectious agents. antiparasitic agents (217) 217
cd4 lymphocyte count (204) 204
oxazines - therapeutic use (199) 199
hiv infections - virology (196) 196
benzoxazines - pharmacology (189) 189
hiv infection (188) 188
viral load (182) 182
microbiology (175) 175
reverse transcriptase inhibitors - administration & dosage (153) 153
benzoxazines - pharmacokinetics (147) 147
hiv infections - complications (143) 143
young adult (142) 142
aged (138) 138
adolescent (137) 137
drug interactions (134) 134
highly active antiretroviral therapy (134) 134
hiv-1 (134) 134
tenofovir (134) 134
antiretroviral therapy (130) 130
hiv-1 - drug effects (128) 128
nevirapine - therapeutic use (123) 123
dosage and administration (122) 122
dose-response relationship, drug (122) 122
drug administration schedule (122) 122
research (121) 121
antiretroviral therapy, highly active (120) 120
nevirapine - adverse effects (119) 119
adenine - analogs & derivatives (117) 117
risk factors (116) 116
lamivudine - therapeutic use (113) 113
oxazines - administration & dosage (113) 113
neurosciences (112) 112
rats (112) 112
analysis (109) 109
anti-hiv agents - pharmacokinetics (109) 109
drug combinations (108) 108
neurosciences & neurology (108) 108
prospective studies (107) 107
immunopathology (106) 106
immunodeficiencies (104) 104
immunodeficiencies. immunoglobulinopathies (104) 104
time factors (104) 104
antiretroviral therapy, highly active - adverse effects (101) 101
aids (100) 100
health aspects (100) 100
pharmacology (97) 97
clinical trials (96) 96
morpholines - pharmacology (96) 96
naphthalenes - pharmacology (95) 95
nevirapine (94) 94
care and treatment (91) 91
pharmacokinetics (90) 90
lamivudine - adverse effects (89) 89
hiv patients (88) 88
pregnancy (88) 88
emtricitabine (87) 87
hiv infections - blood (87) 87
lamivudine - administration & dosage (87) 87
anti-hiv agents (85) 85
double-blind method (85) 85
abridged index medicus (84) 84
child (83) 83
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1369) 1369
German (29) 29
French (16) 16
Spanish (11) 11
Portuguese (6) 6
Dutch (5) 5
Italian (3) 3
Japanese (3) 3
Russian (2) 2
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of infectious diseases, ISSN 0022-1899, 6/2011, Volume 203, Issue 12, pp. 1791 - 1801
HIV/AIDS | Percentage change | RNA | Spine | Bones | Bone density | Arm | Hip | Bone fractures | HIV 1 | Arts | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Fractures, Bone - epidemiology | Male | Oligopeptides - adverse effects | Viral Load | Lamivudine - adverse effects | Tenofovir | Pyridines - adverse effects | Adenine - adverse effects | Ritonavir - adverse effects | Atazanavir Sulfate | Adult | Deoxycytidine - adverse effects | Female | Dideoxynucleosides - adverse effects | Drug Therapy, Combination | Emtricitabine | Adenine - analogs & derivatives | Osteoporosis - chemically induced | Anti-HIV Agents - adverse effects | Risk Factors | Organophosphonates - adverse effects | Benzoxazines - adverse effects | CD4 Lymphocyte Count | Absorptiometry, Photon | Bone Density - drug effects | HIV Infections - complications | Intention to Treat Analysis | HIV Infections - drug therapy | Fractures, Bone - chemically induced | Deoxycytidine - analogs & derivatives | Drug Combinations | Usage | Care and treatment | Ritonavir | Drug utilization | Lamivudine | Efavirenz | Prevention | Abacavir | Dosage and administration | Drug therapy, Combination | Drug therapy | HIV infection | Index Medicus | Abridged Index Medicus | Major and Brief Reports
Journal Article
Journal of neurovirology, ISSN 1355-0284, 12/2017, Volume 23, Issue 6, pp. 795 - 807
Journal Article
AIDS (London), ISSN 0269-9370, 2013, Volume 27, Issue 5, pp. 803 - 813
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Antiviral agents | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | HIV-1 | United States - epidemiology | Lamivudine - administration & dosage | Humans | HIV Seropositivity - mortality | HIV Seropositivity - drug therapy | Nevirapine - adverse effects | Reverse Transcriptase Inhibitors - administration & dosage | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Adenine - adverse effects | Time Factors | Deoxycytidine - adverse effects | HIV Infections - mortality | Dideoxynucleosides - adverse effects | Antiretroviral Therapy, Highly Active - methods | Dideoxynucleosides - administration & dosage | Emtricitabine | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Risk Factors | Organophosphonates - adverse effects | Europe - epidemiology | Benzoxazines - adverse effects | HIV Protease Inhibitors - administration & dosage | Adenine - administration & dosage | Organophosphonates - administration & dosage | Lopinavir - administration & dosage | HIV Infections - drug therapy | Nevirapine - administration & dosage | Deoxycytidine - analogs & derivatives | Drug Combinations | Lopinavir - adverse effects | Cohort Studies | Index Medicus | AIDS/HIV
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 05/2007, Volume 45, Issue 1, pp. 34 - 42
Low-density lipoprotein | Women | Highly active antiretroviral therapy | Lipids | High-density lipoprotein | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Microbiology | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Virology | Cholesterol - blood | Didanosine - adverse effects | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Hispanic Americans - statistics & numerical data | Nevirapine - adverse effects | Tenofovir | Adenine - therapeutic use | Stavudine - therapeutic use | Lamivudine - therapeutic use | Ritonavir - therapeutic use | Dideoxynucleosides - adverse effects | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Organophosphonates - adverse effects | HIV Protease Inhibitors - therapeutic use | HIV-1 | Didanosine - therapeutic use | Multivariate Analysis | Lipoproteins, HDL - blood | United States | HIV Seropositivity - drug therapy | Nevirapine - therapeutic use | Lamivudine - adverse effects | Adenine - adverse effects | Ritonavir - adverse effects | Stavudine - adverse effects | Lipids - blood | Adult | Anti-HIV Agents - therapeutic use | Female | Dideoxynucleosides - therapeutic use | Drug Therapy, Combination | HIV Seronegativity | Nelfinavir - therapeutic use | Fasting | Cross-Sectional Studies | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | European Continental Ancestry Group - statistics & numerical data | Benzoxazines - therapeutic use | Nelfinavir - adverse effects | African Continental Ancestry Group - statistics & numerical data | Triglycerides - blood | HIV Infections - drug therapy | Indinavir - adverse effects | Lipoproteins, LDL - blood | HIV Infections - metabolism | Indinavir - therapeutic use | Measurement | Complications and side effects | Dosage and administration | Blood lipids | Health aspects | HIV infection | Antiretroviral drugs | Drug therapy | Multivariate analysis | Human immunodeficiency virus--HIV | Index Medicus | AIDS/HIV
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 238 - 246
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Organophosphonates - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Adenine - administration & dosage | Benzoxazines - therapeutic use | Organophosphonates - administration & dosage | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Dosage and administration | Efavirenz | Patient outcomes | Clinical trials | Antiretroviral drugs | Drug therapy | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
AIDS (London), ISSN 0269-9370, 2012, Volume 26, Issue 5, pp. 567 - 575
Journal Article
Journal Article
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 05/2013, Volume 63, Issue 1, pp. 77 - 85
raltegravir | HIV | STARTMRK | efavirenz | treatment naive | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | HIV-1 | Oxazines | Humans | Male | Reverse Transcriptase Inhibitors - administration & dosage | Anti-HIV Agents - administration & dosage | Pyrrolidinones - administration & dosage | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Raltegravir Potassium | Emtricitabine | Pyrrolidinones - adverse effects | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Pyrrolidinones - therapeutic use | Benzoxazines - adverse effects | Treatment Outcome | Adenine - administration & dosage | Benzoxazines - therapeutic use | Organophosphonates - administration & dosage | HIV Infections - drug therapy | Deoxycytidine - analogs & derivatives | Drug Combinations | Clinical trials | Patient safety | Antiretroviral drugs | Drug therapy | Comparative analysis | Human immunodeficiency virus--HIV | Index Medicus | AIDS/HIV | Indexing in process
Journal Article
Journal Article